Inhibition of DNMT3B Expression in Activated Hepatic Stellate Cells Overcomes Chemoresistance in the Tumor Microenvironment of Hepatocellular Carcinoma

Researchers aimed to improve HCC therapy by evaluating combination treatment using anti-cancer and anti-fibrosis drugs via identification of novel anti-fibrosis drugs.